Wikisage, the free encyclopedia of the second generation and digital heritage, wishes you merry holidays and a happy new year!
Etifoxine: Difference between revisions
Jump to navigation
Jump to search
m (→Links) |
(type err) |
||
| (8 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
File:Etifoxine_ball-and-stick.png | File:Etifoxine_ball-and-stick.png | ||
</gallery> | </gallery> | ||
[[File: Kjpain-28-4-g001.gif|thumb|450px|Choi, YM, and Kim, KH (2015). Etifoxine for Pain Patients with Anxiety]] | |||
etifoxine is an anticonvulsant and ansiolytic agent. | |||
It is not recommended under the age of 18 years.<ref>https://www.awakebrain.com/stresam-etifoxine</ref> | |||
The known mechanism of action is potentiation of GABA<sub>A</sub> receptor, via stimulation of neurosteroid production. | |||
The etifoxine therapy promoted the regeneration of axons | |||
<ref>[http://www.pnas.org/content/105/51/20505.full.pdf Etifoxine improves peripheral nerve regeneration and functional recovery]</ref> | |||
<ref> | <ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293506/pdf/kjpain-28-4.pdf Etifoxine for Pain Patients with Anxiety]</ref> | ||
==Links== | ==Links== | ||
[https://www.spandidos-publications.com/mmr/8/1/75 Etifoxine promotes glial‑derived neurotrophic factor‑induced neurite outgrowth in PC12 cells] | [https://www.spandidos-publications.com/mmr/8/1/75 Etifoxine promotes glial‑derived neurotrophic factor‑induced neurite outgrowth in PC12 cells] | ||
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364751/pdf/pone.0120473.pdf The Non-Benzodiazepine | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364751/pdf/pone.0120473.pdf do Rego JL, Vaudry D, Vaudry H (2015) The Non-Benzodiazepine Anxiolytic Drug Etifoxine Causes a Rapid, Receptor-Independent Stimulation of Neurosteroid Biosynthesis. PLoS ONE 10(3): e0120473. doi:10.1371/journal.pone.0120473] | ||
<references/> | <references/> | ||
[[Category:GABAA receptor positive allosteric modulators]] | |||
Latest revision as of 19:28, 28 November 2016
etifoxine is an anticonvulsant and ansiolytic agent. It is not recommended under the age of 18 years.[1]
The known mechanism of action is potentiation of GABAA receptor, via stimulation of neurosteroid production. The etifoxine therapy promoted the regeneration of axons [2] [3]
Links
Etifoxine promotes glial‑derived neurotrophic factor‑induced neurite outgrowth in PC12 cells